Riskpilot← Back to searchSign inGet full accessTriomed Innovation AB
ABDissolvedOrg 5590963426Other research and experimental development on natural sciences and engineering · NACE 7219Est. 20170 employees
Revenue 2020
SEK 0
EBITDA margin
—
Equity ratio
0.4%
Financial strength
Net profit 2020
SEK 3K
+250% vs 2019
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 3K | +250% |
| Total assets | SEK 11,5M | +76% |
| Equity | SEK 50K | +6% |
| Employees | 0 | — |
Legal name
Triomed Innovation AB
Org number
5590963426
Legal form
Aktiebolag
NACE code
7219 · Other research and experimental development on natural sciences and engineering
Founded
9 januari 2017
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Bolaget ska bedriva utveckling av medicintekniska produkter inom dialysområdet samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 3 568 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −1 414 | −2 | −1 | — |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −1 414 | −2 | −1 | 0 |
| Net financials | — | — | — | −1 |
| Profit before tax | 1 | −2 | −2 | 3 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | 1 | −2 | −2 | 3 |
| Item | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Total assets | 181 | 3 607 | 6 529 | 11 522 |
| Equity | 51 | 49 | 47 | 50 |
| Long-term debt | 0 | 0 | 0 | 11 162 |
| Short-term debt | 130 | 3 558 | 6 482 | 310 |
| Total debt | 130 | 3 558 | 6 482 | 11 472 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172020
Equity ratio
0.4%
This company
38.2%
Market median
-99% vs market
20172020
Return on equity
6.0%
This company
18.4%
Market median
-67% vs market
20172020
Net profit margin
300000.0%
This company
8.1%
Market median
+3703604% vs market
20172020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172020
Debt / equity
229.44×
This company
0.62×
Market median
-36906% vs market
20172020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KE Chief Auditor | Chief Auditor | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Triomed Innovation AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Elisabeth Löwhagen | Chief Auditor | 0 companies |
| Bengt Anders Wallenås | Board of Directors | 0 companies |
| Hans Johan Bengtsson | Board of Directors | 0 companies |
| Lars Göran Wramner | Chairman | 0 companies |
| Patrick Joseph Greatrex | Board of Directors | 0 companies |